lysine has been researched along with aztreonam in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bush, K; Dougherty, TJ; Gougoutas, JZ; Malley, MF; Ohringer, S; Singer, SB; Sowek, JA | 1 |
| Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
| Kirkpatrick, P; O'Sullivan, BP; Yasothan, U | 1 |
| Elborn, JS; Parkins, MD | 1 |
| Plosker, GL | 2 |
| Bilton, D; Downey, DG; Eustace, JA; Gunaratnam, C; Haworth, CS; Jones, AM; Ketchell, RI; McKone, EF; Peckham, DG; Plant, BJ | 1 |
| Rowbotham, NJ; Smith, S | 1 |
3 review(s) available for lysine and aztreonam
| Article | Year |
|---|---|
Aztreonam lysine: a novel inhalational antibiotic for cystic fibrosis.
Topics: Administration, Inhalation; Adult; Aerosols; Anti-Bacterial Agents; Aztreonam; Cystic Fibrosis; Humans; Lysine; Nebulizers and Vaporizers; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors; Treatment Outcome | 2010 |
Aztreonam lysine for inhalation solution: in cystic fibrosis.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Aztreonam; Cystic Fibrosis; Humans; Lysine; Pharmaceutical Solutions; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Aztreonam; Child; Child, Preschool; Cystic Fibrosis; Humans; Lysine; Middle Aged; Quality of Life; Randomized Controlled Trials as Topic; Tobramycin; Young Adult | 2022 |
5 other study(ies) available for lysine and aztreonam
| Article | Year |
|---|---|
Substitution of lysine at position 104 or 240 of TEM-1pTZ18R beta-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam.
Topics: Aztreonam; beta-Lactamases; Binding Sites; Cephalosporins; Escherichia coli; Hydrolysis; Kinetics; Lysine; Models, Molecular; Molecular Conformation; Mutagenesis, Site-Directed; Protein Conformation; Serine; Substrate Specificity | 1991 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Inhaled aztreonam.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Aztreonam; Cystic Fibrosis; Drug Discovery; Humans; Lysine; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome | 2010 |
Aztreonam lysine for inhalation solution in cystic fibrosis: profile report.
Topics: Administration, Inhalation; Adult; Aztreonam; Cystic Fibrosis; Humans; Infant; Lysine; Solutions; Young Adult | 2011 |
A treatment evaluator tool to monitor the real-world effectiveness of inhaled aztreonam lysine in cystic fibrosis.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Aztreonam; Body Mass Index; Cystic Fibrosis; Drug Monitoring; Female; Forced Expiratory Volume; Hospitalization; Humans; Lysine; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Treatment Outcome | 2017 |